Efficacy and safety of anlotinib monotherapy or combination therapy in the treatment of patients with advanced non-small cell lung cancer: a retrospective real-world study conducte... by Jia Wei, Yan Zhang, Ying Zheng, Chengxing Ma, Qi Zhao, Yongsheng Wang, Liyun Miao, Jingjing Ding

Subjects: Get full text

Cost Disparities with Age in the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) in Ontario, Canada by Ying Wang, Greg Pond, Amiram Jacob Gafni, Chung Yin Kong, Peter M. Ellis

Subjects: “…advanced NSCLC…”
Get full text

Evaluation Value of Blood Biomarker Tests for Efficacy of EGFR-TKI in Advanced NSCLC Treatment by Rui FAN, Yonghui WU, Zhan GU, Yanbin PENG, Lixin WANG

Subjects: “…advanced nsclc…”
Get full text

Prognostic factors influencing overall survival in stage IV EGFR-mutant NSCLC patients treated with EGFR-TKIs by Linwu Kuang, Yuchen Zhang, Hao Wang, Peng Wang, Yangkai Li

Subjects: Get full text